Watchmaker Genomics

Watchmaker Genomics is a biotechnology company based in Boulder, Colorado, with additional facilities in Cape Town, South Africa. Founded in 2019, the company focuses on precision enzyme engineering and molecular biology tools. It aims to advance research in areas such as next-generation sequencing (NGS), personalized medicine, synthetic biology, and molecular diagnostics. The company develops a variety of products, including DNA and RNA NGS solutions, high-fidelity amplification kits, and custom enzymes. These offerings are designed to enhance the accuracy and efficiency of genomic analysis. Watchmaker Genomics also provides custom capabilities for genomics, including OEM supply and contract services. The leadership team includes CEO Trey Foskett and Chief Innovation Officer Eric van Der Walt, both of whom bring extensive experience in the field. The company has successfully raised significant funding to support its innovative work.